Intellia Therapeutics Inc buy Barclays PLC
Start price
08.11.24
/
50%
€15.58
Target price
08.11.25
€51.38
Performance (%)
-41.87%
End price
09.11.25
€9.06
Summary
This prediction ended on 09.11.25 with a price of €9.06. Massive losses of -41.87% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 11.663% | 11.663% | 11.519% |
| iShares Core DAX® | 2.573% | 5.333% | 8.273% |
| iShares Nasdaq 100 | 4.858% | 0.449% | 27.079% |
| iShares Nikkei 225® | 5.590% | -0.586% | 48.553% |
| iShares S&P 500 | 3.250% | 2.500% | 23.351% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Barclays PLC from $76.00 to $55.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.12
07.11.25
07.11.25
€12.13
07.11.26
07.11.26
27.34%
07.08.26
07.08.26
Stopped prediction by Barclays_PLC for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.82
28.02.25
28.02.25
€25.05
28.02.26
28.02.26
11.87%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.00
04.08.23
04.08.23
€81.52
04.08.24
04.08.24
-40.22%
05.08.24
05.08.24